Erste Asset Management’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Erste Asset Management’s Portfolio FPRX Stock Details FPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-367,274	Closed	-$6.7M	–	516
2020 Q4	$6.7M	Sell	367,274 -42,726	-10%	-$535K	0.19%	142
2020 Q3	$1.93M	Hold	410,000	–	–	0.07%	253
2020 Q2	$2.5M	Hold	410,000	–	–	0.1%	206
2020 Q1	$931K	Sell	410,000 -39,750	-9%	-$169K	0.05%	263
2019 Q4	$1.94M	Buy	449,750 +80,000	+22%	+$317K	0.09%	212
2019 Q3	$1.45M	Buy	369,750 +15,000	+4%	+$82.3K	0.08%	218
2019 Q2	$2.14M	Buy	354,750 +79,000	+29%	+$755K	0.11%	168
2019 Q1	$3.71M	Buy	275,750 +95,000	+53%	+$1.08M	0.21%	119
2018 Q4	$1.6M	Buy	+180,750	New	+$2.15M	0.11%	181

Other funds holding FPRX

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Erste Asset Management's FPRX Position: Q1 2021 in Review

Erste Asset Management sold out of Five Prime Therapeutics, Inc. (FPRX) in Q1 2021, closing a stake of 367,274 shares — an estimated $6.7M sold.

Erste Asset Management first reported a position in FPRX in Q4 2018 and held it in 9 quarters. The position peaked at $6.7M in Q4 2020. 147 funds tracked by Wall St. Rank hold FPRX as of Q1 2021.

Erste Asset Management reported no remaining Five Prime Therapeutics, Inc. position as of Q1 2021 after selling out during the quarter.
Erste Asset Management sold 367,274 Five Prime Therapeutics, Inc. shares in Q1 2021, an estimated $6.7M.
Erste Asset Management first reported a position in Five Prime Therapeutics, Inc. in Q4 2018 and held it in 9 quarters.
Erste Asset Management's Five Prime Therapeutics, Inc. position peaked at $6.7M in Q4 2020.
147 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q1 2021.

Based on Erste Asset Management's 13F filing for Q1 2021, filed 25 Nov 2024.